Author:
Zeichner Simon B.,Herna Stuart,Mani Aruna,Ambros Tadeu,Montero Alberto J.,Mahtani Reshma L.,Ahn Eugene R.,Vogel Charles L.
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Howlader N, Noone AM, Krapcho M et al (2013) SEER Cancer Statistics Review, 1975-2010, National Cancer Institute, Bethesda. http://seer.cancer.gov/csr/1975_2010/ . Based on November 2012 SEER data submission, posted to the SEER web site
2. Dawood S, Broglio K, Ensor J et al (2010) Survival differences among women with de novo stage IV and relapsed breast cancer. Ann Oncol 21(11):2169–2174. doi: 10.1093/annonc/mdq220
3. Lobbezoo DJA, van Kampen RJW, Voogd AC et al (2015) Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? Br J Cancer 112(9):1445–1451. doi: 10.1038/bjc.2015.127
4. Rahman Z, Frye D, Smith T (2000) Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin containing chemotherapy. Cancer 40(19990101):1–2
5. Nieto Y, Nawaz S, Jones RB et al (2002) Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer. J Clin Oncol 20(3):707–718
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献